These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 16567806)

  • 21. Disulfide bridge engineering in the tachykinin NK1 receptor.
    Elling CE; Raffetseder U; Nielsen SM; Schwartz TW
    Biochemistry; 2000 Feb; 39(4):667-75. PubMed ID: 10651631
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Conformational constraining of inactive and active States of a seven transmembrane receptor by metal ion site engineering in the extracellular end of transmembrane segment V.
    Rosenkilde MM; David R; Oerlecke I; Benned-Jensen T; Geumann U; Beck-Sickinger AG; Schwartz TW
    Mol Pharmacol; 2006 Dec; 70(6):1892-901. PubMed ID: 16971553
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Complex of an active mu-opioid receptor with a cyclic peptide agonist modeled from experimental constraints.
    Fowler CB; Pogozheva ID; Lomize AL; LeVine H; Mosberg HI
    Biochemistry; 2004 Dec; 43(50):15796-810. PubMed ID: 15595835
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ghrelin receptor inverse agonists: identification of an active peptide core and its interaction epitopes on the receptor.
    Holst B; Lang M; Brandt E; Bach A; Howard A; Frimurer TM; Beck-Sickinger A; Schwartz TW
    Mol Pharmacol; 2006 Sep; 70(3):936-46. PubMed ID: 16798937
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An activation switch in the rhodopsin family of G protein-coupled receptors: the thyrotropin receptor.
    Urizar E; Claeysen S; Deupí X; Govaerts C; Costagliola S; Vassart G; Pardo L
    J Biol Chem; 2005 Apr; 280(17):17135-41. PubMed ID: 15722344
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular basis for agonism in the BB3 receptor: an epitope located on the interface of transmembrane-III, -VI, and -VII.
    Gbahou F; Holst B; Schwartz TW
    J Pharmacol Exp Ther; 2010 Apr; 333(1):51-9. PubMed ID: 20065020
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gating function of isoleucine-116 in TM-3 (position III:16/3.40) for the activity state of the CC-chemokine receptor 5 (CCR5).
    Steen A; Sparre-Ulrich AH; Thiele S; Guo D; Frimurer TM; Rosenkilde MM
    Br J Pharmacol; 2014 Mar; 171(6):1566-79. PubMed ID: 24328926
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular Mechanism of Action for Allosteric Modulators and Agonists in CC-chemokine Receptor 5 (CCR5).
    Karlshøj S; Amarandi RM; Larsen O; Daugvilaite V; Steen A; Brvar M; Pui A; Frimurer TM; Ulven T; Rosenkilde MM
    J Biol Chem; 2016 Dec; 291(52):26860-26874. PubMed ID: 27834679
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of an in situ disulfide cross-linking strategy to map proximities between amino acid residues in transmembrane domains I and VII of the M3 muscarinic acetylcholine receptor.
    Hamdan FF; Ward SD; Siddiqui NA; Bloodworth LM; Wess J
    Biochemistry; 2002 Jun; 41(24):7647-58. PubMed ID: 12056896
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Light-driven activation of beta 2-adrenergic receptor signaling by a chimeric rhodopsin containing the beta 2-adrenergic receptor cytoplasmic loops.
    Kim JM; Hwa J; Garriga P; Reeves PJ; RajBhandary UL; Khorana HG
    Biochemistry; 2005 Feb; 44(7):2284-92. PubMed ID: 15709741
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Construction of a high affinity zinc switch in the kappa-opioid receptor.
    Thirstrup K; Elling CE; Hjorth SA; Schwartz TW
    J Biol Chem; 1996 Apr; 271(14):7875-8. PubMed ID: 8626461
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Beta2 adrenergic receptor activation. Modulation of the proline kink in transmembrane 6 by a rotamer toggle switch.
    Shi L; Liapakis G; Xu R; Guarnieri F; Ballesteros JA; Javitch JA
    J Biol Chem; 2002 Oct; 277(43):40989-96. PubMed ID: 12167654
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alanine exchanges of polar amino acids in the transmembrane domains of a platelet-activating factor receptor generate both constitutively active and inactive mutants.
    Ishii I; Izumi T; Tsukamoto H; Umeyama H; Ui M; Shimizu T
    J Biol Chem; 1997 Mar; 272(12):7846-54. PubMed ID: 9065450
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Split-receptors in the tachykinin neurokinin-1 system--mutational analysis of intracellular loop 3.
    Nielsen SM; Elling CE; Schwartz TW
    Eur J Biochem; 1998 Jan; 251(1-2):217-26. PubMed ID: 9492287
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular mechanism of action of monocyclam versus bicyclam non-peptide antagonists in the CXCR4 chemokine receptor.
    Rosenkilde MM; Gerlach LO; Hatse S; Skerlj RT; Schols D; Bridger GJ; Schwartz TW
    J Biol Chem; 2007 Sep; 282(37):27354-27365. PubMed ID: 17599916
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Random mutagenesis of the M3 muscarinic acetylcholine receptor expressed in yeast. Identification of point mutations that "silence" a constitutively active mutant M3 receptor and greatly impair receptor/G protein coupling.
    Schmidt C; Li B; Bloodworth L; Erlenbach I; Zeng FY; Wess J
    J Biol Chem; 2003 Aug; 278(32):30248-60. PubMed ID: 12750375
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The minor binding pocket: a major player in 7TM receptor activation.
    Rosenkilde MM; Benned-Jensen T; Frimurer TM; Schwartz TW
    Trends Pharmacol Sci; 2010 Dec; 31(12):567-74. PubMed ID: 20870300
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metal ion enhanced binding of AMD3100 to Asp262 in the CXCR4 receptor.
    Gerlach LO; Jakobsen JS; Jensen KP; Rosenkilde MR; Skerlj RT; Ryde U; Bridger GJ; Schwartz TW
    Biochemistry; 2003 Jan; 42(3):710-7. PubMed ID: 12534283
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of aromatic transmembrane residues of the delta-opioid receptor in ligand recognition.
    Befort K; Tabbara L; Kling D; Maigret B; Kieffer BL
    J Biol Chem; 1996 Apr; 271(17):10161-8. PubMed ID: 8626577
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of group-conserved residues in the helical core of beta2-adrenergic receptor.
    Chelikani P; Hornak V; Eilers M; Reeves PJ; Smith SO; RajBhandary UL; Khorana HG
    Proc Natl Acad Sci U S A; 2007 Apr; 104(17):7027-32. PubMed ID: 17438264
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.